Wird geladen...
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
Lipid-lowering therapy is used very commonly nowadays not only for the optimization of the lipid profile but also to reduce cardiovascular risk. However, some studies have linked the use of certain lipid-lowering agents with an increased risk for impaired glycemic control and new-onset diabetes mell...
Gespeichert in:
| Veröffentlicht in: | Drugs Context |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioExcel Publishing Ltd
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267678/ https://ncbi.nlm.nih.gov/pubmed/30515229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212562 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|